Prelude therapeutics to present at the 11th annual svb leerink global healthcare conference

Wilmington, del., feb. 11, 2022 (globe newswire) -- prelude therapeutics inc. (nasdaq: prld), a clinical-stage precision oncology company, today announced that kris vaddi, phd, chief executive officer, will present virtually at the 11th annual svb leerink global healthcare conference on friday, february 18 at 1:40 p.m. et.
PRLD Ratings Summary
PRLD Quant Ranking